Carl Zeiss Meditec has officially completed the acquisition of IanTECH, a privately held company focused on technology solutions for micro-interventional cataract surgery, headquartered in Reno, Nevada. News of this agreement was first announced earlier in October.
Among the products to be integrated into the ZEISS portfolio of cataract surgical solutions is the miLOOP™ Lens Fragmentation Device, the first in a line of ophthalmic tools engineered by IanTECH for its micro-interventional cataract surgery platform. Using micro-thin super-elastic, self-expanding nitinol filament technology, the miLOOP™ device is designed to offer cataract surgeons the ability to achieve full thickness lens fragmentation for any grade cataract minimizing the intraocular ultrasonic vibrations and phaco power. Additional technologies for lens removal are under development.
Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh innovative approach in the field of phaco. IanTECH’s surgical technology is designed to change the future of managing cataracts.
Updates and additional information can be found on at https://www.zeiss.com/meditec/us or at https://www.iantechmed.com/.